A double-blind, randomized, placebo-controlled pilot trial to determine the efficacy and safety of ibudilast, a potential glial attenuator, in chronic migraine
Yuen H Kwok,1 James E Swift,1 Parisa Gazerani,2 Paul Rolan1 1Discipline of Pharmacology, University of Adelaide, Level 5 Medical School North, South Australia, Australia; 2Department of Health Science & Technology, Aalborg University, Aalborg, Denmark Background: Chronic migraine (CM) is pr...
Main Authors: | Kwok YH, Swift JE, Gazerani P, Rolan P |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-10-01
|
Series: | Journal of Pain Research |
Subjects: | |
Online Access: | https://www.dovepress.com/a-double-blind-randomized-placebo-controlled-pilot-trial-to-determine--peer-reviewed-article-JPR |
Similar Items
-
Ibudilast suppresses oxaliplatin-induced mechanical allodynia and neurodegeneration in rats
by: Nobuaki Egashira, et al.
Published: (2021-09-01) -
Emerging Potential of the Phosphodiesterase (PDE) Inhibitor Ibudilast for Neurodegenerative Diseases: An Update on Preclinical and Clinical Evidence
by: Efthalia Angelopoulou, et al.
Published: (2022-12-01) -
Ibudilast (MN-166) in amyotrophic lateral sclerosis- an open label, safety and pharmacodynamic trial
by: Suma Babu, et al.
Published: (2021-01-01) -
Migraine and Mood in Children
by: Parisa Gazerani
Published: (2021-04-01) -
A Bidirectional View of Migraine and Diet Relationship
by: Gazerani P
Published: (2021-02-01)